Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. (PRAX) — Form SCHEDULE 13G/A: Ownership over 5% (passive) (amendment)
About this filing
Praxis Precision Medicines, Inc. (PRAX) filed Form SCHEDULE 13G/A (ownership over 5% (passive) (amendment)) with the SEC on Aug 14, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.
Key facts
- Document
- —
More PRAX filings
- 10-Q
Filed Nov 9, 2026
- 8-K
Filed Nov 9, 2026
- SC 13G/A
Filed Nov 5, 2026
- 10-Q
Filed Aug 6, 2026
- 8-K
Filed Aug 6, 2026
- 4
Filed Jul 8, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.